Celanese (CE) and Secarna Partner for Antisense Therapies [Yahoo! Finance]
Celanese Corporation Celanese Corporation (CE)
Last celanese corporation celanese corporation earnings: 4/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.celanese.com
Company Research
Source: Yahoo! Finance
ASOs are synthetic compounds that target specific messenger RNA to block the creation of proteins involved in the progression of a variety of diseases, including cardiometabolic, central nervous system, oncologic and uncommon disorders. Antisense therapy is a novel, commercially validated therapeutic method. However, it generally necessitates frequent administration or large dosages to ensure uptake at the desired site of action, resulting in a substantial treatment burden for patients. The Celanese VitalDose Drug Delivery Platform and Secarna's proprietary ASO Drug Discovery and Development Platform will be used to create ASO-eluting implants with the potential to reduce dosing frequency, reduce off-target immune responses and improve targeting to provide better patient outcomes for a variety of indications. The VitalDose medication Delivery Platform has a long history of usage in approved parenteral drugs in the United States and Europe, and it delivers consistent, controlled-r
Show less
Read more
Impact Snapshot
Event Time:
CE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CE alerts
High impacting Celanese Corporation Celanese Corporation news events
Weekly update
A roundup of the hottest topics
CE
News
- Global Encapsulant Material for PV Module Market to rise at a 7.90% CAGR through 2034, reaching US$ 12 billion | Future Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Celanese Announces Kim K.W. Rucker as New Lead Independent DirectorBusiness Wire
- Celanese Co. (NYSE: CE) had its price target raised by analysts at Royal Bank of Canada from $165.00 to $171.00. They now have an "outperform" rating on the stock.MarketBeat
- Celanese to Hold First Quarter Earnings Conference Call on May 9, 2024Business Wire
- Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share [Yahoo! Finance]Yahoo! Finance
CE
Earnings
- 2/20/24 - Miss
CE
Sec Filings
- 3/21/24 - Form ARS
- 3/21/24 - Form DEFA14A
- 3/21/24 - Form DEF
- CE's page on the SEC website